Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SARS CORP.Listing unverified | OtherD (derivative) | $80K | SEC | ||
SARS CORP.Listing unverified | Other | $32K | SEC | ||
SARS CORP.Listing unverified | Buy | $4.8K | conv 49Cluster | SEC | |
SARS CORP.Listing unverified | Sell | $12.6K | SEC | ||
SARS CORP.Listing unverified | Sell | $23.4K | SEC | ||
SARS CORP.Listing unverified | Buy | $136.4K | conv 77First in 12mo | SEC |